Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as ¿-aminobutyric acidA receptor agonists

Jette Gellert Petersen, Rikke Bergmann, Henriette A. Møller, Charlotte Grube Jørgensen, Birgitte Nielsen, Jan Kehler, Karla Frydenvang, Jesper Kristensen, Thomas Balle, Anders A. Jensen, Uffe Kristiansen, Bente Frølund

17 Citations (Scopus)

Abstract

A series of bioisosteric 4-(aminomethyl)-1-hydroxypyrazole (4-AHP) analogues of muscimol, a GABAA receptor agonist, has been synthesized and pharmacologically characterized at native and selected recombinant GABAA receptors. The unsubstituted 4-AHP analogue (2a) (EC 50 19 μM, Rmax 69%) was a moderately potent agonist at human α1β2γ2 GABAA receptors, and in SAR studies substitutions in the 3- and/or 5-position were found to be detrimental to binding affinities. Ligand-receptor docking in an α1β2γ2 GABAA receptor homology model along with the obtained SAR indicate that 2a and muscimol share a common binding mode, which deviates from the binding mode of the structurally related antagonist series based on 4-(piperidin-4-yl)-1- hydroxypyrazole (4-PHP, 1). Selectivity for α1β 2γ2 over ρ1 GABAA receptors was observed for the 5-chloro, 5-bromo, and 5-methyl substituted analogues of 2a illustrating that even small differences in structure can give rise to subtype selectivity.

Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume56
Issue number3
Pages (from-to)993-1006
ISSN0022-2623
DOIs
Publication statusPublished - 14 Feb 2013

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of 4-(aminomethyl)-1-hydroxypyrazole analogues of muscimol as ¿-aminobutyric acidA receptor agonists'. Together they form a unique fingerprint.

Cite this